Sorry to miss it!

Unrelated to #NephJC mystery case Did you know that Alport syndrome was discovered in 1927 by Cecil Alport? It was called hereditary familial congenital hemorrhagic nephritis Genetic transmission was demonstrated by 💉 serum from pts to 2 rabbits🐰 pubmed.ncbi.nlm.nih.gov/20773074/

Only one of us has over 50 years of service to Test Account --Keith Hruska, the Legendary Nephrologist at the far right.

Congratulations to Dr. Shumeng Jiang, PhD, the first PhD student of Hani Suleiman Hani Suleiman, MD, PhD , co-mentored by Guy Genin & myself. "Mechanobiology of podocyte adhesion and injury in the kidney glomerulus". Outstanding thesis defense!

🔥😀Super-super excited to report the publication of "Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression" in Nature Genetics rdcu.be/dONoW by Amin Abedini and Jon Levinsohn #kidney

Such a productive and fun weekend with this terrific group!

Deidra Crews, MD, ScM, FASN, MACP American Society of Nephrology Baltimore Orioles Tod Ibrahim Dan Weiner Prabir Roy-Chaudhury patrick nachman Samir M. Parikh Jeffrey H. Miner Jeff Thank you to Deidra, ASN, and my fellow councilors for a productive and thoroughly enjoyable American Society of Nephrology Council meeting in Baltimore. A great time was had by all and we got a lot of work done too!

So proud of O'Brien Kidney Resource Alliance summer student and WashU undergrad Teija Suhas for her wrap-up presentation on assaying variants of uncertain significance in patients with suspected #AlportSyndrome. Thanks WU in STL Nephrology SOAR program! 😍the coffee filter analogy!

Very proud to share our work on histopathological based analysis of ST kidney data. So grateful to my wonderfull mentor Benjamin D. Humphreys @humphreyslab !!! ajp.amjpathol.org/article/S0002-…

Have you submitted your late-breaking clinical trial for #KidneyWk? This year's meeting features multiple oral sessions and more presentation time for high-impact research. Share your Phase 2, 3, or 4 clinical trial on a global stage. Learn more: asn.kdny.info/wqL350SxVm5

Don’t miss this great opportunity!

This is one of the most insightful articles American Society of Nephrology I have read in a while about where Nephrology as a specialty is headed. For sure things will not remain the same. Which scenario do you feel is more likely: kidneynews.org/view/journals/…

I voted. Have you??

Very enjoyable time at the best bar and then best restaurant in St. Louis!

Hot off the press! "Mechanisms of assembly and remodelling of the extracellular matrix" is now out in Nature Reviews Molecular Cell Biology doi.org/10.1038/s41580… It is a privilege to have been asked to review the current state of #ECM research and discuss exciting emerging research avenues, a 🧵:

So glad to be able to participate in this collaboration.

Fantastic talk on emerging therapies for Alport Syndrome by Kaye E Brathwaite MD #GlomerularSymposium Women In Nephrology

Our own ⭐️ and recognized authority on #complement, Anuja Java, MD (she/her) speaks to rapt audience on C3 Glomerulopathy 👏👏 #GlomerularSymposium Women In Nephrology Forum for Women in Medicine at WashU (FWIM)

Thanks to Rachel Lennon for the Alport spectrum diagram!

Interesting aspect of Dr. Alport's 1927 paper: “Hereditary nephritis is a definite entity; kidneys in these patients are more susceptible to damage by the toxin of an unknown organism than is the case in the normal person.” A reasonable (for 1927) but incorrect hypothesis.